UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

~~Current~~CURRENT ~~Report Pursuant~~REPORT

toPURSUANT ~~Section~~ TO SECTION 13 orOR 15(d) ~~of the~~OF

~~Securities~~THE ~~Exchange~~SECURITIES ~~Act~~EXCHANGE ofACT OF 1934

Date of Report (Date of ~~Earliest~~earliest ~~Event Reported~~event reported): ~~March~~ 2May 24, 2012

CONMED HEALTHCARE MANAGEMENT, INC.

(Exact name of ~~Registrant~~registrant as ~~Specified~~specified in ~~its~~ ~~Charter~~its charter)

Delaware

0-27554

42-1297992

(State or other jurisdiction of

incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

(State or Other Jurisdiction of Incorporation)

0-27554		42-1297992
(Commission File Number)		(I.R.S. Employer Identification Number)

7250 Parkway Dr.

Suite 400

Hanover, MD

(Address of principal executive offices)

21076

(Zip Code)

Registrant’s telephone number, including area code: (410) 567-5520

~~(Registrant’s~~Check ~~Telephone~~the ~~Number,~~appropriate ~~including~~box below if the Form 8-K filing is intended ~~Area~~to ~~Code~~simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

~~Check~~¨ ~~the~~Written ~~appropriate box below if the Form 8-K filing is intended~~communications pursuant to ~~simultaneously~~Rule ~~satisfy~~425 ~~the filing obligation of the Registrant~~ under ~~any of~~ the ~~following~~Securities ~~provisions~~Act (17 ~~see~~CFR ~~General Instruction A~~230.~~2 below~~425):

o ¨ Soliciting ~~Written~~material ~~communications~~ pursuant to Rule ~~425~~14a-12 under the ~~Securities~~Exchange Act (17 CFR ~~230~~240.~~425~~14a-12).

~~o Soliciting~~¨ ~~material~~Pre-commencement communications pursuant to Rule ~~14a~~14d-122(b) under the Exchange Act (17 CFR 240.~~14a~~14d-122(b).)

o ¨ Pre-commencement communications pursuant to Rule ~~14d~~13e-24(bc) under the Exchange Act (17 CFR 240.~~14d~~13e-24(bc)).

~~o Pre-commencement~~Item ~~communications~~5.07. ~~pursuant~~Submission toof ~~Rule~~Matters ~~13e-4(c)~~to ~~under~~a ~~the~~Vote ~~Exchange~~of ~~Act~~Security ~~(17 CFR 240~~Holders.~~13e-4(c)).~~

~~Item~~On 2May 24, 2012, Conmed Healthcare Management, Inc.02 (the “Company”) held its 2012 Annual Meeting of Stockholders (the “2012 Annual Meeting”). ~~Results~~The items listed below were submitted to a vote of ~~Operations~~the stockholders present, in person or by proxy, and ~~Financial~~entitled ~~Condition~~to vote at the 2012 Annual Meeting. Final voting results are shown below.

On(1) ~~March~~Election 2,of ~~2012,~~the ~~Conmed~~following ~~Healthcare~~individuals ~~Management,~~to ~~Inc.~~serve ~~(the~~as ~~“Company”)~~directors ~~issued~~of athe ~~press~~Company ~~release~~until ~~announcing its financial results for~~ the ~~three~~next ~~months~~annual ~~and~~meeting ~~year~~or ~~ended~~until ~~December~~their ~~31,~~successors ~~2011.~~have ~~The~~been ~~press~~duly ~~release is~~elected ~~attached~~or asappointed ~~Exhibit~~and 99qualified.~~1 to this Current Report on Form 8-K.~~

The information set forth in this Item 2.02 and the attached Exhibit 99.1 is furnished to, but shall not be deemed “filed” with, the Securities and Exchange Commission for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise incorporated by reference into any filing pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such a filing.

Election of Directors	For	Withheld	Abstain	Broker Non-Votes
John Pappajohn	10,778,717	698,255	0	1,677,034
Richard W. Turner	10,801,144	675,828	0	1,677,034
Edward B. Berger	11,339,711	137,261	0	1,677,034
John W. Colloton	11,343,211	133,761	0	1,677,034
Charles Crocker	11,339,711	137,261	0	1,677,034
Jeffrey W. Runge	11,339,711	137,261	0	1,677,034

~~Item~~(2) ~~9.01.~~Ratification ~~Financial~~of ~~Statements~~the ~~and~~appointment ~~Exhibits~~by the Audit Committee of the Company’s Board of Directors of McGladrey & Pullen, LLP to serve as the independent auditors of the Company for the fiscal year ending December 31, 2012.

(d) Exhibits

Ratification of Independent Auditors	For	Against	Abstain	Broker Non-Votes
	13,123,431	30,575	0	0

Exhibit No.	Description
99.1	Press release dated March 2, 2012

(3) Amendment of the Company’s 2007 Stock Option Plan, as amended (the “2007 Plan”) to increase the number of shares of common stock, par value $.0001 per share, reserved for issuance under the 2007 Plan from three million one hundred thousand (3,100,000) to four million one hundred thousand (4,100,000) (“Amendment No. 4”). A copy of Amendment No. 4 to the 2007 Plan is attached hereto as Exhibit 10.1.

This Current Report on Form 8-K may contain, among other things, certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, (i) statements with respect to the Company’s plans, objectives, expectations and intentions; and (ii) other statements that are not historical facts including statements which may be identified by words such as "may," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "projects," "potentially," or similar expressions. These statements are based upon the current beliefs and expectations of the Company's management, and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. These forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company's control) including, without limitation: the Company's ability to increase revenue and to continue to obtain new contracts, contract renewals and extensions; inflation exceeding the Company’s projection of the inflation rate of cost of services under multi-year contracts; the ability to obtain bonds; decreases in occupancy levels or disturbances at detention centers; malpractice litigation; the ability to utilize third-party administrators for out-of-facility care; compliance with laws and government regulations, including those relating to healthcare; competition; investigation and auditing of our contracts by government agencies; termination of contracts due to lack of government appropriations; material adverse changes in economic and industry conditions in the healthcare market; negative publicity regarding the provision of correctional healthcare services; dependence on key personnel and the ability to hire skilled personnel; influences of certain stockholders; increases in healthcare costs; insurance; public company obligations; limited liability of directors and officers; the Company’s ability to meet the NYSE Amex continued listing standards; and stock price volatility. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the U.S. Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, as amended, for the year ended December 31, 2011. Investors and security holders are urged to read these documents free of charge on the SEC's web site at www.sec.gov. The Company does not undertake to publicly update or revise its forward-looking statements, whether as a result of new information, future events or otherwise.

Approval of Amendment to 2007 Plan	For	Against	Abstain	Broker Non-Votes
	8,981,295	2,492,877	2,800	1,677,034

~~SIGNATURES~~Item 9.01. Financial Statements and Exhibits.

~~Pursuant~~(d) ~~to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~Exhibits

	CONMED HEALTHCARE MANAGEMENT, INC.
Exhibit No.	Description
Date: March 2, 2012	By:	/s/ Thomas W. Fry
10.1	Amendment No. 4 to the 2007 Plan.
		Name: Thomas W. Fry
		Title: Senior Vice President, Chief Financial Officer and Secretary

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CONMED HEALTHCARE MANAGEMENT, INC.

	By:	__/s/ Thomas W. Fry________________
	Name:	Thomas W. Fry
	Title:	Senior Vice President, Chief Financial Officer and Secretary

Date: May 30, 2012

Filing Compare · Conmed Healthcare Management, Inc.